During the corresponding time, Grail Inc recorded a revenue increase by 28.11 % year on year, sequentially revenue fell by -6.45 %. While revenue at the Grail Inc 's corporate clients
Grail Inc's Comment on Sales, Marketing and Customers
The company provides services for individuals over the age of 50, addressing a global population exceeding 300 million, including more than 100 million in the United States. Its commercially available MCED screening test, Galleri, is utilized by healthcare providers and integrated into existing care pathways such as annual health checks. The company's customers and market segments include leading healthcare systems, employers, digital health platforms, payors, and life insurance providers. It maintains partnerships with academic and community medical centers, key opinion leaders, and governmental policy and advocacy organizations. Additionally, the company engages in discussions with the NHS to promote further adoption of Galleri.
By In a significant milestone that promises to reshape the landscape of biotechnology and retail trading alike, GRAIL, Inc., a company at the forefront of early cancer detection, is set to begin trading on the Nasdaq Stock Exchange tomorrow. Formerly known as GRAIL, LLC, the company has transitioned to GRAIL, Inc. and will use the ticker symbol GRAL. This move on June 25, 2024 marks a critical juncture not only for GRAIL but also for the broader medical and financial communities, both of which are poised to witness substantial impacts. The Rise of a Medical PioneerFounded with the ambitious goal of revolutionizing cancer diagnostics through cutting-edge technology, GRAIL leverages next-generation sequencing ...
Grail Inc’s Comment on Sales, Marketing and Customers
The company provides services for individuals over the age of 50, addressing a global population exceeding 300 million, including more than 100 million in the United States. Its commercially available MCED screening test, Galleri, is utilized by healthcare providers and integrated into existing care pathways such as annual health checks. The company's customers and market segments include leading healthcare systems, employers, digital health platforms, payors, and life insurance providers. It maintains partnerships with academic and community medical centers, key opinion leaders, and governmental policy and advocacy organizations. Additionally, the company engages in discussions with the NHS to promote further adoption of Galleri.
Sources:
Grail Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Grail Inc’s corporate clients.
For your research, we’ve provided 9 tables on Grail Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
97.66 %